Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Here's Why You Should Consider Investing in JAZZ Stock Now
12:03pm, Monday, 17'th Oct 2022
JAZZ's new drugs like Xywav, Rylaze and Zepzelca, along with the recently-acquired drugs, are expected to generate 65% of product revenues in 2022.
Relmada (RLMD) Lead Candidate Fails Late-Stage Depression Study
04:55pm, Friday, 14'th Oct 2022 Zacks Investment Research
Relmada's (RLMD) phase III study, evaluating REL-1017 in major depressive disorder, fails to achieve statistical significance. Shares plunge 80% following the news.
Relmada's Trial Failure Removes Competitor Risk For This Company's Newly Launched Depression Product
03:30pm, Friday, 14'th Oct 2022 Benzinga
On Thursday, Relmada Therapeutics Inc (NASDAQ: RLMD) reported a failed Phase 3 Major Depressive Disorder monotherapy trial for its REL-1017.
BofA analyst noted this was a potential competitor to A
Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday
08:53am, Friday, 14'th Oct 2022 Benzinga
Gainers
Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.
FedNat Holding Company (NASDAQ: FNHC) shares surged 56.5% to
Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday
06:46am, Friday, 14'th Oct 2022 Benzinga
U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session.
Nutex Health Inc. (NASDAQ: NUTX) jumped
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
03:44pm, Thursday, 13'th Oct 2022 Benzinga
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.
AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) rose 51.2% to $0.1212. AnPac Bio recently
Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket
11:56am, Thursday, 13'th Oct 2022 Benzinga
Gainers
Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTec
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
11:46am, Thursday, 13'th Oct 2022
Source: ra2 studio/Shutterstock Today may be less than stellar for Relmada Therapeutics (NASDAQ: RLMD ), but it's certainly a great day for Axsome Therapeutics (NASDAQ: AXSM ). Apparently, Relmada's d
Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:24am, Thursday, 13'th Oct 2022 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Meta Materials Inc. (NASDAQ: MMAT) shares climbed 13.3% to $1.19 in pr
3 Red-Hot Stocks That Could Continue to Beat the Market
10:30am, Thursday, 13'th Oct 2022 The Motley Fool
Investors are betting on these companies' revenue growth prospects.
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
09:25am, Thursday, 13'th Oct 2022
Relmada stock crashed Thursday after its depression treatment failed a final-phase test, helping bolster rival Axsome. AXSM stock surged.
3 Red-Hot Stocks That Could Continue to Beat the Market
06:30am, Thursday, 13'th Oct 2022
Investors are betting on these companies' revenue growth prospects.
Acadia (ACAD) Thrives on Nuplazid, Overdependence a Concern
02:57pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Acadia's (ACAD) lead drug, Nuplazid, is approved for treating hallucinations and delusions associated with Parkinson's disease psychosis. Sole dependence on Nuplazid for growth remains an overhang.
Got $1,000? These 3 Stocks Could Double Your Money in 5 Years.
02:00pm, Wednesday, 12'th Oct 2022 The Motley Fool
All three stocks are worth keeping a lot longer than half a decade.
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
10:00am, Wednesday, 12'th Oct 2022 The Motley Fool
Vertex already generates billions in revenue -- but there may be more to come.
